文献速递牙周病

牙周治疗对糖尿病前期患者HbA1c的影响

Effect of Periodontal Treatment on HbA1c among Patients with Prediabetes.
PubMed 文献 · J Dent Res · 2018-10-16

该研究为多中心随机对照试验的事后探索性分析,评估非手术牙周治疗联合或不联合全身抗生素对牙周炎患者HbA1c和hsCRP的影响。结果显示糖尿病前期患者HbA1c从5.9%降至15.5个月时的5.4%,27.5个月时回升至5.6%,46%恢复正常。

要点

  • 非手术牙周治疗可使糖尿病前期牙周炎患者HbA1c短期下降。
  • 27.5个月时46%的糖尿病前期患者HbA1c恢复正常。
  • 正常HbA1c组和糖尿病前期组hsCRP中位数均下降。

核心结论

  • 非手术牙周治疗可能改善糖尿病前期牙周炎患者的血糖水平。

研究设计与样本

  • 多中心随机对照试验「Antibiotika und Parodontitis」的探索性事后分析,前瞻性、分层、双盲设计。
  • 纳入牙周炎患者按HbA1c分组:正常组(≤5.7%,n=218)、糖尿病前期组(5.7%<HbA1c<6.5%,n=101)、未知糖尿病组(HbA1c≥6.5%,n=8),观察27.5个月。

主要发现

  • 非手术牙周治疗使两组平均探诊深度降低>1 mm。
  • 正常HbA1c组HbA1c在观察期间保持5.0%(95%CI 4.9%至6.1%)不变。
  • 糖尿病前期组HbA1c从5.9%(95%CI 5.9%至6.0%)降至15.5个月时的5.4%(95%CI 5.3%至5.5%),27.5个月时升至5.6%(95%CI 5.4%至5.7%)。
  • 27.5个月时46%的糖尿病前期患者HbA1c恢复正常,47.9%保持不变,6.3%进展为糖尿病。
  • 正常HbA1c组和糖尿病前期组hsCRP中位数分别从1.2和1.4 mg/L降至0.7和0.7 mg/L。

临床怎么用

  • 对糖尿病前期合并牙周炎的患者,非手术牙周治疗可能有助于短期血糖改善。

局限性

  • 证据有限,为探索性事后分析,尚不清楚代谢状态改善能否持续超过3个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Evidence is limited regarding whether periodontal treatment improves hemoglobin A1c (HbA1c) among people with prediabetes and periodontal disease, and it is unknown whether improvement of metabolic status persists >3 mo. In an exploratory post hoc analysis of the multicenter randomized controlled trial "Antibiotika und Parodontitis" (Antibiotics and Periodontitis)-a prospective, stratified, double-blind study-we assessed whether nonsurgical periodontal treatment with or without an adjunctive systemic antibiotic treatment affects HbA1c and high-sensitivity C-reactive protein (hsCRP) levels among periodontitis patients with normal HbA1c (≤5.7%, n = 218), prediabetes (5.7% < HbA1c < 6.5%, n = 101), or unknown diabetes (HbA1c ≥ 6.5%, n = 8) over a period of 27.5 mo. Nonsurgical periodontal treatment reduced mean pocket probing depth by >1 mm in both groups. In the normal HbA1c group, HbA1c values remained unchanged at 5.0% (95% CI, 4.9% to 6.1%) during the observation period. Among periodontitis patients with prediabetes, HbA1c decreased from 5.9% (95% CI, 5.9% to 6.0%) to 5.4% (95% CI, 5.3% to 5.5%) at 15.5 mo and increased to 5.6% (95% CI, 5.4% to 5.7%) after 27.5 mo. At 27.5 mo, 46% of periodontitis patients with prediabetes had normal HbA1c levels, whereas 47.9% remained unchanged and 6.3% progressed to diabetes. Median hsCRP values were reduced in the normal HbA1c and prediabetes groups from 1.2 and 1.4 mg/L to 0.7 and 0.7 mg/L, respectively. Nonsurgical periodontal treatment may improve blood glucose values among periodontitis patients with prediabetes (ClinicalTrials.gov NCT00707369).

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Kocher T, Holtfreter B, Petersmann A, et al. Effect of Periodontal Treatment on HbA1c among Patients with Prediabetes. J Dent Res. 2018. PMID: 30326764. doi:10.1177/0022034518804185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。